Bausch Health Companies Inc. (BHC) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Bausch Health Companies Inc. (BHC) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

BHC Income Statement

Bausch Health Companies Inc. (BHC) annual income statement — 30-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	2.94B	2.85B	2.52B	2.8B	2.68B	2.53B	2.26B	2.56B	2.51B	2.4B	2.15B	2.41B	2.24B	2.17B	1.94B	2.19B	2.05B	1.97B	1.92B	2.2B
Revenue Growth %	9.7%	12.73%	11.73%	9.26%	6.81%	5.29%	4.92%	6.27%	12.15%	10.89%	10.75%	9.8%	9.38%	10.17%	1.36%	-0.14%	-3.08%	-6.33%	-5.38%	-0.77%
Cost of Goods Sold	735M	772M	738M	798M	750M	764M	701M	727M	696M	719M	640M	705M	623M	649M	582M	652M	584M	577M	551M	626M
COGS % of Revenue	24.99%	27.07%	29.24%	28.54%	27.97%	30.2%	31.03%	28.41%	27.73%	29.92%	29.73%	29.28%	27.84%	29.95%	29.94%	29.73%	28.54%	29.33%	28.73%	28.51%
Gross Profit	2.21B	2.08B	1.79B	2B	1.93B	1.77B	1.56B	1.83B	1.81B	1.68B	1.51B	1.7B	1.61B	1.52B	1.36B	1.54B	1.46B	1.39B	1.37B	1.57B
Gross Margin %	75.01%	72.93%	70.76%	71.46%	72.03%	69.8%	68.97%	71.59%	72.27%	70.08%	70.27%	70.72%	72.16%	70.05%	70.06%	70.27%	71.46%	70.67%	71.27%	71.49%
Gross Profit Growth %	14.24%	17.78%	14.63%	9.06%	6.45%	4.87%	2.97%	7.57%	12.32%	10.94%	11.09%	10.51%	10.47%	9.21%	-0.37%	-1.85%	-4.38%	-6.59%	-5.92%	0.13%
Operating Expenses	1.22B	1.3B	1.26B	1.17B	1.29B	1.31B	1.27B	1.27B	1.5B	1.29B	1.23B	1.34B	1.6B	1.11B	1.19B	1.78B	1.22B	1.23B	1.08B	1.2B
OpEx % of Revenue	41.58%	45.76%	50.12%	41.81%	48.3%	51.74%	56.04%	49.79%	59.6%	53.89%	57.22%	55.69%	71.54%	51.04%	61.06%	81.03%	59.53%	62.48%	56.41%	54.78%
Selling, General & Admin	834M	907M	861M	882M	795M	894M	867M	816M	850M	832M	789M	762M	715M	711M	719M	656M	661M	676M	598M	639M
SG&A % of Revenue	28.36%	31.8%	34.11%	31.55%	29.65%	35.34%	38.38%	31.89%	33.86%	34.62%	36.65%	31.64%	31.95%	32.81%	36.99%	29.91%	32.31%	34.37%	31.18%	29.1%
Research & Development	141M	173M	163M	51M	247M	159M	143M	163M	161M	159M	151M	152M	153M	156M	143M	142M	133M	128M	127M	122M
R&D % of Revenue	4.79%	6.07%	6.46%	1.82%	9.21%	6.28%	6.33%	6.37%	6.41%	6.62%	7.01%	6.31%	6.84%	7.2%	7.36%	6.48%	6.5%	6.51%	6.62%	5.56%
Other Operating Expenses	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Operating Income	983M	775M	521M	829M	636M	457M	292M	558M	318M	389M	281M	362M	14M	412M	175M	-236M	244M	161M	285M	367M
Operating Margin %	33.42%	27.17%	20.64%	29.65%	23.72%	18.06%	12.93%	21.81%	12.67%	16.19%	13.05%	15.03%	0.63%	19.01%	9%	-10.76%	11.93%	8.19%	14.86%	16.71%
Operating Income Growth %	54.56%	69.58%	78.42%	48.57%	100%	17.48%	3.91%	54.14%	2171.43%	-5.58%	60.57%	253.39%	-94.26%	155.9%	-38.6%	-164.31%	-57.49%	159.63%	228.96%	7440%
EBITDA	1.27B	1.06B	816M	1.12B	942M	764M	597M	865M	640M	707M	601M	691M	315M	727M	494M	124M	579M	508M	637M	730M
EBITDA Margin %	43.08%	37.03%	32.33%	40.02%	35.14%	30.2%	26.43%	33.8%	25.5%	29.42%	27.91%	28.7%	14.08%	33.55%	25.41%	5.65%	28.3%	25.83%	33.21%	33.24%
EBITDA Growth %	34.5%	38.22%	36.68%	29.36%	47.19%	8.06%	-0.67%	25.18%	103.17%	-2.75%	21.66%	457.26%	-45.6%	43.11%	-22.45%	-83.01%	-39.44%	279.1%	250%	72.58%
D&A (Non-Cash Add-back)	284M	281M	295M	290M	306M	307M	305M	307M	322M	318M	320M	329M	301M	315M	319M	360M	335M	347M	352M	363M
EBIT	995M	744M	-952M	453M	630M	605M	283M	594M	544M	426M	299M	507M	494M	381M	227M	428M	378M	286M	332M	494M
Net Interest Income	-385M	-385M	-392M	-388M	-397M	-452M	-319M	-328M	-339M	-342M	-346M	-356M	-333M	-312M	-301M	-301M	-382M	-407M	-360M	-342M
Interest Income	13M	11M	10M	9M	15M	13M	11M	9M	7M	8M	9M	7M	6M	7M	6M	6M	3M	3M	2M	1M
Interest Expense	398M	396M	402M	397M	412M	465M	330M	337M	346M	350M	355M	363M	339M	319M	307M	307M	385M	410M	362M	343M
Other Income/Expense	-386M	-427M	-1.88B	-773M	-418M	-317M	-339M	-349M	-339M	-341M	-350M	-369M	-340M	-333M	-311M	-121M	195M	-290M	-367M	-346M
Pretax Income	597M	348M	-1.35B	56M	218M	140M	-47M	209M	-21M	47.99M	-69M	-7M	-326M	79M	-136M	-357M	439M	-129M	-82M	21M
Pretax Margin %	20.3%	12.2%	-53.64%	2%	8.13%	5.53%	-2.08%	8.17%	-0.84%	2%	-3.2%	-0.29%	-14.57%	3.65%	-7%	-16.28%	21.46%	-6.56%	-4.28%	0.96%
Income Tax	151M	88M	77M	159M	37M	12M	39M	111M	71M	48.99M	7.96M	40M	56M	52M	73M	53M	36M	10M	-16M	-51M
Effective Tax Rate %	25.29%	25.29%	-5.69%	283.93%	16.97%	8.57%	-82.98%	53.11%	-338.1%	102.08%	-11.54%	-571.43%	-17.18%	65.82%	-53.68%	-14.85%	8.2%	-7.75%	19.51%	-242.86%
Net Income	436M	258M	-1.42B	-112M	179M	148M	-58M	93M	-85M	10M	-63.71M	-39M	-378M	26M	-201M	-410M	399M	-145M	-69M	69M
Net Margin %	14.82%	9.05%	-56.38%	-4.01%	6.68%	5.85%	-2.57%	3.63%	-3.39%	0.42%	-2.96%	-1.62%	-16.89%	1.2%	-10.34%	-18.7%	19.5%	-7.37%	-3.6%	3.14%
Net Income Growth %	143.58%	74.32%	-2353.45%	-220.43%	310.59%	1380%	8.97%	338.46%	77.51%	-61.54%	68.3%	90.49%	-194.74%	117.93%	-191.3%	-694.2%	112.23%	75.63%	88.69%	145.1%
Net Income (Continuing)	446M	260M	-1.43B	-103M	181M	128M	-86M	98M	-92M	-1M	-77M	-47M	-382M	27M	-209M	-410M	403M	-139M	-66M	72M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	987M	969M	977M	929.31M	920.1M	911M	943M	957M	932M	948M	941M	940M	945M	705.06M	945M	952M	958M	946M	75M	72M
EPS (Diluted)	1.15	0.68	-3.79	-0.31	0.47	0.40	-0.16	0.25	-0.23	0.03	-0.17	-0.11	-1.03	0.07	-0.58	-1.13	1.10	-0.38	-0.18	0.19
EPS Growth %	144.68%	70%	-2268.75%	-224%	304.35%	1381.48%	5.88%	327.27%	77.67%	-62.34%	70.69%	90.27%	-193.64%	118.87%	-222.22%	-694.74%	111.54%	77.11%	89.29%	144.19%
EPS (Basic)	1.16	0.67	-3.79	-0.31	0.48	0.41	-0.16	0.25	-0.23	0.03	-0.17	-0.11	-1.03	0.07	-0.58	-1.13	1.10	-0.38	-0.18	0.19
Diluted Shares Outstanding	380.7M	378.1M	372.8M	370.53M	375.5M	373.1M	369.6M	372M	368.4M	370.2M	366.8M	365.24M	365.4M	367.1M	363.3M	361.9M	363.4M	362.5M	360.8M	364.1M
Basic Shares Outstanding	375.5M	375M	372.8M	370.53M	371.3M	370.9M	369.6M	372M	368.4M	367.9M	366.8M	365.24M	365.4M	364.8M	363.3M	361.9M	362.5M	362.2M	360.8M	360M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-